Moody National Bank Trust Division’s Acadia Pharmaceuticals ACAD Stock Holding History

Moody National Bank Trust Division’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-166	Closed	-$4K	–	360
2019 Q1	$4K	Sell	166 -76	-31%	-$1.77K	﹤0.01%	1018
2018 Q4	$4K	Buy	+242	New	+$4.7K	﹤0.01%	900
2015 Q1	–	Sell	-26,894	Closed	-$854K	–	234
2014 Q4	$854K	Sell	26,894 -15,526	-37%	-$440K	0.06%	92
2014 Q3	$1.05M	Buy	42,420 +31,447	+287%	+$735K	0.07%	66
2014 Q2	$248K	Sell	10,973 -42,429	-79%	-$886K	0.02%	245
2014 Q1	$1.3M	Sell	53,402 -43,380	-45%	-$1.1M	0.09%	48
2013 Q4	$2.42M	Hold	96,782	–	–	0.16%	17
2013 Q3	$2.66M	Buy	96,782 +33,751	+54%	+$706K	0.21%	13
2013 Q2	$1.14M	Buy	+63,031	New	+$868K	0.09%	49

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Moody National Bank Trust Division's ACAD Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Acadia Pharmaceuticals (ACAD) in Q2 2019, closing a stake of 166 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in ACAD in Q2 2013 and held it in 9 quarters. The position peaked at $2.66M in Q3 2013. 196 funds tracked by Wall St. Rank hold ACAD as of Q2 2019.

Moody National Bank Trust Division reported no remaining Acadia Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Moody National Bank Trust Division sold 166 Acadia Pharmaceuticals shares in Q2 2019, an estimated $4K.
Moody National Bank Trust Division first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Moody National Bank Trust Division's Acadia Pharmaceuticals position peaked at $2.66M in Q3 2013.
196 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.